Bin Jiang

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

Jesús F. San Miguel, Rudolf Schlag, Nuriet K. Khuageva et al. · New England Journal of Medicine · 2008 · 1.9K citations · Full text

Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial

María‐Victoria Mateos, Paul G. Richardson, Rudolf Schlag et al. · Journal of Clinical Oncology · 2010 · 431 citations · Full text

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

Hong‐Hu Zhu, Xiaohui Zhang, Ya‐Zhen Qin et al. · Blood · 2013 · 321 citations · Full text

Persistent Overall Survival Benefit and No Increased Risk of Second Malignancies With Bortezomib-Melphalan-Prednisone Versus Melphalan-Prednisone in Patients With Previously Untreated Multiple Myeloma

Jesús F. San Miguel, Rudolf Schlag, Nuriet K. Khuageva et al. · Journal of Clinical Oncology · 2012 · 265 citations · Full text

Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report

Dao‐Pei Lu, Jing-Ying Qiu, Bin Jiang et al. · Blood · 2002 · 209 citations